Entheon Biomedical (XCNQ:ENBI) EBIT per Share : C$-0.05 (TTM As of Feb. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical EBIT per Share?

Entheon Biomedical's EBIT per Share for the three months ended in Feb. 2024 was C$-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.05.

During the past 3 years, the average EBIT per Share Growth Rate was 39.60% per year. During the past 5 years, the average EBIT per Share Growth Rate was 14.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Entheon Biomedical's EBIT per Share or its related term are showing as below:

XCNQ:ENBI' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -263.4 Med: -43.7 Max: 39.6
Current: 39.6

During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Entheon Biomedical was 39.60% per year. The lowest was -263.40% per year. And the median was -43.70% per year.

XCNQ:ENBI's 3-Year EBIT Growth Rate is ranked better than
88.25% of 1311 companies
in the Biotechnology industry
Industry Median: 3.5 vs XCNQ:ENBI: 39.60

Entheon Biomedical's EBIT for the three months ended in Feb. 2024 was C$-0.08 Mil.

Entheon Biomedical EBIT per Share Historical Data

The historical data trend for Entheon Biomedical's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical EBIT per Share Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

EBIT per Share

Get a 7-Day Free Trial

-0.55

-0.24

-1.51

-0.61

-0.05

Entheon Biomedical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EBIT per Share	Get a 7-Day Free Trial															-0.02	-0.01	-0.02	-0.01	-0.01

Entheon Biomedical EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Entheon Biomedical's EBIT per Share for the fiscal year that ended in Nov. 2023 is calculated as

	EBIT per Share		(A: Nov. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.314	/	5.909
=	-0.05

Entheon Biomedical's EBIT per Share for the quarter that ended in Feb. 2024 is calculated as

	EBIT per Share		(Q: Feb. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.078	/	5.909
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.05

Entheon Biomedical (XCNQ:ENBI) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Entheon Biomedical EBIT per Share Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (XCNQ:ENBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

ENTBF:USA 1XU1:Germany

Address

999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5

Website

https://www.entheonbiomedical.com

Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines